Matisse Pharmaceuticals
1 clinical trials · Sponsor
◉ Watch Matisse Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study in Healthy Subjects to Assess the Safety and Tolerability of a 120-hour Continuous Infusion of M6229 (NCT07285603) | Matisse Pharmaceuticals | 2024-11-21 |
Track Matisse Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.